Biodesix, Inc. BDSX Contingent Consideration Liability (Non-Current)
Contingent Consideration Liability (Non-Current) at other companies
Other financials
Where this comes from
Reported directly by Biodesix, Inc. in its filing.
Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent.
The official record: Biodesix, Inc.’s 10-Q, filed November 7, 2023, on SEC EDGAR. View the filing →
Ask your AI about Biodesix, Inc.'s contingent consideration liability (non-current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biodesix, Inc.'s contingent consideration liability (non-current)?
- Biodesix, Inc. (BDSX) reported contingent consideration liability (non-current) of $5.18M in Q3 2023.
- How has Biodesix, Inc.'s contingent consideration liability (non-current) changed year-over-year?
- Biodesix, Inc.'s contingent consideration liability (non-current) decreased by 75.2% year-over-year, from $20.89M to $5.18M.
- What is the long-term trend for Biodesix, Inc.'s contingent consideration liability (non-current)?
- Over 2 years (2020 to 2022), Biodesix, Inc.'s contingent consideration liability (non-current) has grown at a -21.1% compound annual growth rate (CAGR), from $29.93M to $18.65M.